APA (7th ed.) Citation

Wendler, J., Lewis, R. I., Kutilina, A., Knott, M., Isbell, L. K., Valk, E., . . . Schorb, E. Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma. Ferrata Storti Foundation.

Chicago Style (17th ed.) Citation

Wendler, Julia, et al. Pre-phase Treatment with Rituximab and High-dose Methotrexate to Re-evaluate Eligibility for Intensive Induction Treatment of Frail Patients with Central Nervous System Lymphoma. Ferrata Storti Foundation.

MLA (9th ed.) Citation

Wendler, Julia, et al. Pre-phase Treatment with Rituximab and High-dose Methotrexate to Re-evaluate Eligibility for Intensive Induction Treatment of Frail Patients with Central Nervous System Lymphoma. Ferrata Storti Foundation.